Can we improve fluid balance and cardiovascular outcomes in peritoneal dialysis patients?

Peritoneal Dialysis International

Volumn 26, Issue 1, 2006, Pages 49-52

  Woodrow, Graham ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYPERTONIC SOLUTION; ICODEXTRIN;

ALBUMIN BLOOD LEVEL; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIALYSATE; ECHOCARDIOGRAPHY; FLUID BALANCE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; HYDRATION; HYPERTENSION; HYPOALBUMINEMIA; LONG TERM CARE; MORTALITY; NOTE; OUTCOME ASSESSMENT; PATIENT MONITORING; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; SODIUM RESTRICTION; SURVIVAL RATE; ULTRAFILTRATION; ELECTROLYTE BALANCE; METABOLISM; PHYSIOLOGY;

CARDIOVASCULAR DISEASES; HUMANS; PERITONEAL DIALYSIS; PROGNOSIS; SURVIVAL RATE; WATER-ELECTROLYTE BALANCE;

EID: 33745487506     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600108     Document Type: Note

References (31)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(Suppl 3):S112-19.
2. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized controlled trial. J Am Soc Nephrol 2002; 13:1307-20.
3. Ateş K, Nergizoglu G, Keven K, Şen A, Kutlat S, Ertürk Ş, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60:767-76.
4. Lameire N, van Biesen W. Importance of blood pressure and volume control in peritoneal dialysis patients. Perit Dial Int 2001; 21:206-11.
5. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47:186-92.
6. Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 2001; 16:1459-64.
7. Koc M, Toprak A, Tezcan H, Bihorac A, Akoglu E, Ozener IC. Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients. Nephrol Dial Transplant 2002; 17:1661-6.
8. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001; 12:2768-74.
9. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001; 12: 2759-67.
10. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994; 4:1486-90.
11. Konings CJAM, Kooman JP, Schonk M, Dammers R, Cheriex E, Meulemans APP, et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22:477-87.
12. Cocchi R, Espotti ED, Fabbri A, Lucatello A, Sturani A, Quarello F, et al. Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrol Dial Transplant 1999; 14:1536-40.
13. Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 2001; 16:2207-13.
14. Tzamaloukas AH, Saddler MC, Murata GH, Malhotra D, Sena P, Simon D, et al. Symptomatic fluid retention in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995; 6:198-206.
15. Plum J, Schoenicke G, Kleophas W, Kulas W, Steffens F, Azem A, et al. Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods. Nephrol Dial Transplant 2001; 16:2378-85.
16. Takeda K, Nakamoto M, Hirakata H, Baba M, Kubo M, Fujishima M. Disadvantage of long-term CAPD for preserving cardiac performance: an echocardiographic study. Am J Kidney Dis 1998; 32:482-7.
17. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30:334-42.
18. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al. Survival of functionally anuric patients on automated peritoneal dialysis. J Am Soc Nephrol 2003; 14: 2948-57.
19. Charra B, Calemard E, Ruffet M, Chazot C, Terrat J-C, Vanel T, et al. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41:1286-91.
20. Katzarski KS, Charra B, Luik AJ, Nisell J, Divino Filho JC, Leypoldt JK, et al. Fluid status and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 1999; 14:369-75.
21. Woodrow G, Oldroyd B, Stables G, Gibson J, Turney JH, Brownjohn AM. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis. Nephrol Dial Transplant 2000; 15:862-6.
22. Jones CH, Wells L, Stoves JJ, Farquhar F, Woodrow G. Can reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 2002; 39:872-5.
23. Günal AI, Duman S, Özkahaya M, Töz H, Aşci G, Akçiçek F, et al. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 588-93.
24. Aşci G, Özkahya M, Duman S, Toz H, Erten S, Ok E. Volume control associated with better cardiac function in long-term peritoneal dialysis patients. Perit Dial Int 2006; 26: 85-88.
25. Wright MJ, Woodrow G, O'Brien S, King NA, Dye L, Blundell JE, et al. Polydipsia: a feature of peritoneal dialysis. Nephrol Dial Transplant 2004; 19:1581-6.
26. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12:2158-62.
27. Moist LM, Port FK, Orzol SM, Young EW, Ostbyte T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11: 556-64.
28. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson A-C, et al. Icodextrin improves fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-44.
29. Li PK-T, Chow K-M, Wong TY-H, Leung C-B, Szeto C-C. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. Ann Intern Med 2003; 139:105-12.
30. Konings CJAM, Kooman JP, Schonck M, Gladziwa U, Wirtz J, Van Den Wall Bake AW, et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63:1556-63.
31. Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B, et al. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002; 39:862-71.